180 related articles for article (PubMed ID: 33590401)
41. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
42. Application of a multi-institutional nomogram predicting salvage whole brain radiation-free survival to patients treated with postoperative stereotactic radiotherapy for brain metastases.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2021 Apr; 25(2):141-146. PubMed ID: 33422416
[TBL] [Abstract][Full Text] [Related]
43. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
[TBL] [Abstract][Full Text] [Related]
44. Assessing the Effectiveness of Systemic Therapy after Stereotactic Radiosurgery on Cancer Recurrence and All-Cause Mortality.
Al-Khindi T; Shen CJ; Peng L; Redmond KJ; Lim M; Kleinberg LR; Bettegowda C
World Neurosurg; 2019 Sep; 129():e572-e581. PubMed ID: 31158536
[TBL] [Abstract][Full Text] [Related]
45. The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review.
Lancellotta V; Del Regno L; Di Stefani A; Fionda B; Marazzi F; Rossi E; Balducci M; Pampena R; Morganti AG; Mangoni M; Lebbe C; Garbe C; Longo C; Schinzari G; Tagliaferri L; Peris K
Radiol Med; 2022 Jul; 127(7):773-783. PubMed ID: 35606609
[TBL] [Abstract][Full Text] [Related]
46. Management of patients with ≥4 brain metastases using stereotactic radiosurgery boost after whole brain irradiation.
Dincoglan F; Sager O; Gamsiz H; Uysal B; Demiral S; Oysul K; Sirin S; Caglan A; Beyzadeoglu M
Tumori; 2014; 100(3):302-6. PubMed ID: 25076242
[TBL] [Abstract][Full Text] [Related]
47. Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer.
Harris S; Chan MD; Lovato JF; Ellis TL; Tatter SB; Bourland JD; Munley MT; deGuzman AF; Shaw EG; Urbanic JJ; McMullen KP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e53-9. PubMed ID: 22342297
[TBL] [Abstract][Full Text] [Related]
48. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of synchronous stereotactic radiotherapy with temozolomide combined with whole brain radiotherapy in treating brain metastases originating from non-small cell lung cancer.
Liu P; Ren R; You D; Liu J
J BUON; 2020; 25(4):1771-1778. PubMed ID: 33099912
[TBL] [Abstract][Full Text] [Related]
50. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
Andrews DW; Scott CB; Sperduto PW; Flanders AE; Gaspar LE; Schell MC; Werner-Wasik M; Demas W; Ryu J; Bahary JP; Souhami L; Rotman M; Mehta MP; Curran WJ
Lancet; 2004 May; 363(9422):1665-72. PubMed ID: 15158627
[TBL] [Abstract][Full Text] [Related]
51. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.
Rades D; Kueter JD; Hornung D; Veninga T; Hanssens P; Schild SE; Dunst J
Strahlenther Onkol; 2008 Dec; 184(12):655-62. PubMed ID: 19107346
[TBL] [Abstract][Full Text] [Related]
52. Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients : Statistical analysis.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Bund C; Chambrelant I; Antoni D; Noel G
Strahlenther Onkol; 2022 Jun; 198(6):527-536. PubMed ID: 35294567
[TBL] [Abstract][Full Text] [Related]
53. Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.
Miyakawa A; Shibamoto Y; Takemoto S; Serizawa T; Otsuka S; Hirai T
Int J Clin Oncol; 2017 Apr; 22(2):250-256. PubMed ID: 27826659
[TBL] [Abstract][Full Text] [Related]
54. The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.
Kaidar-Person O; Zagar TM; Deal A; Moschos SJ; Ewend MG; Sasaki-Adams D; Lee CB; Collichio FA; Fried D; Marks LB; Chera BS
Anticancer Drugs; 2017 Jul; 28(6):669-675. PubMed ID: 28368903
[TBL] [Abstract][Full Text] [Related]
55. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
57. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
[TBL] [Abstract][Full Text] [Related]
58. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
[TBL] [Abstract][Full Text] [Related]
59. Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts.
Pintea B; Baumert B; Kinfe TM; Gousias K; Parpaley Y; Boström JP
Radiat Oncol; 2017 Nov; 12(1):177. PubMed ID: 29132382
[TBL] [Abstract][Full Text] [Related]
60. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
